Head to Head Comparison: Crispr Theraptc (CRSP) and Editas Medicine (EDIT)Dispatch TribunalCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR from Prevotella and Fra… Continue reading
ModernMedicineTisagenlecleucel (Kymriah) for Acute Lymphoblastic LeukemiaModernMedicineQuote The FDA granted regular approval to tisagenlecleucel (Kymriah, Novartis) for the treatment of ALL that is refractory or in relapse in patients up to age 25.1 … Continue reading
ModernMedicineTisagenlecleucel (Kymriah) for Acute Lymphoblastic LeukemiaModernMedicineQuote The FDA granted regular approval to tisagenlecleucel (Kymriah, Novartis) for the treatment of ALL that is refractory or in relapse in patients up to age 25.1 … Continue reading
Dr. Inman on Biomarkers for Immunotherapy in Bladder CancerOncLiveBrant Inman, MD, surgical oncologist, urologic oncologist, Duke Cancer Center discusses biomarkers for immunotherapy in patients with bladder cancer. There are not currently good biomark… Continue reading
OncLiveCombinations Required to Further Advance Adoptive T-Cell TherapyOncLiveA variety of adoptive T-cell therapy strategies have shown promise in clinical trials with recent FDA approvals granted to chimeric antigen receptor (CAR)-modified T-cell the… Continue reading
FortuneBrainstorm Health: Antibiotic Resistance, Stem Cell Skin Regeneration, Postpartum Depression DrugFortuneDuring the next 12 months, the CDC estimates that at least 2 million illnesses and 23,000 deaths will be caused by bacterial or fungal infect… Continue reading
Medscape |
FDA OKs Merck drug that prevents infection post-stem cell transplant
Business Insider (Reuters) – Merck & Co Ltd’s drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug Administration, the drugmaker said on Thursday. Merck said the drug, which is expected to be … Letermovir (Prevymis) Okayed for Stem Cell Transplant InfectionMedscape FDA Approves Prevymis to Prevent CMV Among Stem Cell Transplant PatientsInfectious Disease Special Edition |